Q3 2019 Investor Presentation
Propeller has demonstrated compelling clinical outcomes
i
Impact of the Propeller solution tracking inhaler usage and location
SABA use over time
Symptom free days
Healthcare utilization
# per day
%
Events
-25%
79
2.0
+32%
75
1.5
-50%
50
50
1.0
25
0.5
Uncontrolled
0.0
COPD
0
50 100
150
Uncontrolled
Asthma
Drives a decrease in
medication
Adherence
%
59
0
200
0
50
100 150 200
Before
After
Drives an improvement in
Drives a reduction in
healthcare utilization
QOL
QoL: Rescue Inhaler use per day
Acute care utilization
# times used
Events per 100 patient years
1.5
Pre-enrollment
13
12
Post-enrollment
+58%
57
1.0
36
-75%
0.5
0.0
Control Intervention
1
Drives an
180
Drives an
improvement in
improvement in
©2019 ResMed I Q3 2019 Investor Presentation | 23
adherence
QOL
6
5
2
0
365
ED + Hosp. ED
Hosp.
Drives a reduction in
healthcare utilization
ResMedView entire presentation